Elizabeth E. Tallett's most recent trade in Moderna Inc was a trade of 19,134 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 19,134 | 19,134 | - | - | Stock Option (Right to Buy) | |
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 4,058 | 4,058 | - | - | Restricted Stock Units | |
| Elevance Health | Elizabeth E. Tallett | Director | 15 May 2024 | 388 | 10,291 (0%) | 0% | 0 | Common Stock | ||
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 7,557 | 7,557 | - | - | Stock Option (Right to Buy) | |
| Elevance Health | Elizabeth E. Tallett | Director | 10 May 2023 | 457 | 9,903 (0%) | 0% | 0 | Common Stock | ||
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 6,134 | 6,134 | - | - | Stock Option (Right to Buy) | |
| Elevance Health | Elizabeth E. Tallett | Director | 18 May 2022 | 440 | 9,446 (0%) | 0% | 0 | Common Stock | ||
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 5,415 | 5,415 | - | - | Stock Option (Right to Buy) | |
| Moderna | Elizabeth E. Tallett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 703 (0%) | 0% | 0 | Common Stock | |
| Moderna | Elizabeth E. Tallett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 0 | - | - | Restricted Stock Units | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 74 | 8,128 | - | - | Phantom Stock Units | |
| Elevance Health | Elizabeth E. Tallett | Director | 26 May 2021 | 493 | 9,006 (0%) | 0% | 0 | Common Stock | ||
| Principal Financial Group | Elizabeth E. Tallett | Retired Director | Sale of securities on an exchange or to another person at price $ 64.94 per share. | 20 May 2021 | 22,800 | 44,432 (0%) | 0% | 64.9 | 1,480,632 | Common Stock |
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 4,081 | 4,081 | - | - | Stock Option (Right to Buy) | |
| Moderna | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 703 | 703 | - | - | Restricted Stock Units | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 596 | 67,232 (0%) | 0% | 0 | Common Stock | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 73 | 8,051 | - | - | Phantom Stock Units | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 752 | 66,636 (0%) | 0% | 0 | Common Stock | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 93 | 7,978 | - | - | Phantom Stock Units | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2020 | 916 | 65,884 (0%) | 0% | 0 | Common Stock | |
| Principal Financial Group | Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2020 | 113 | 7,885 | - | - | Phantom Stock Units |